Clinical Scorecard: The Critical Role of Medication Reviews in Ophthalmic Care

At a Glance

Key Highlights

• Hydroxychloroquine can cause dose- and duration-dependent retinal toxicity, particularly parafoveal photoreceptor and retinal pigment epithelium damage; appropriate retinal screening is important.
• Current or prior tamsulosin use is associated with intraoperative floppy iris syndrome during cataract surgery, including after the medication has been discontinued.
• Amiodarone commonly causes corneal verticillata and is rarely associated with optic neuropathy.
• Medication review can help connect ocular findings with systemic conditions and identify incomplete or inaccurate medical histories.
• Technicians should recognize and communicate relevant findings to the physician, not diagnose patients.

Guideline-Based Recommendations

Diagnosis

• Review the medication list alongside the patient's medical history and ocular findings.
• Ask why the patient takes each relevant medication, how long they have taken it, and whether medications have changed since the last visit.
• Recognize medication-associated findings, including hydroxychloroquine-related retinal toxicity, tamsulosin-associated surgical risk, and amiodarone-associated corneal verticillata.

Management

• Identify current or prior tamsulosin use during preoperative cataract consultations.
• Perform relevant testing within the technician's scope and communicate significant findings or medication-related concerns to the physician.
• Use medication history to help identify systemic conditions that may affect evaluation, treatment, or surgery.

Monitoring & Follow-up

• Recognize the importance of appropriate retinal screening for patients taking hydroxychloroquine.
• Ask patients about medication changes since their previous visit and review the medication list with them.

Risks

• Hydroxychloroquine may cause dose- and duration-dependent retinal toxicity.
• Tamsulosin is associated with intraoperative floppy iris syndrome during cataract surgery, even after discontinuation.
• Amiodarone commonly causes corneal verticillata and can rarely be associated with optic neuropathy.
• Red flags identified in the article include sudden vision loss, sudden pain, new relative afferent pupillary defect, and new disc edema.

Patient & Prescribing Data

Patients taking systemic medications who are undergoing ophthalmic evaluation or cataract-surgery assessment.

The article discusses medication review and recognition of ocular effects; it does not provide prescribing or dosing recommendations.

Clinical Best Practices

• Treat medication review as part of the ocular history, not solely as an administrative task.
• Connect medications with their indications, associated systemic conditions, and potential ocular effects.
• Ask whether medication information changes what testing should be obtained before the patient is roomed.
• Train technicians to recognize and report clinically significant patterns while maintaining the boundary that diagnosis is the physician's role.

Related Resources & Content

• The Critical Role of Medication Reviews in Ophthalmic Care